Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder

Journal of Clinical Psychiatry

Volumn 73, Issue 5, 2012, Pages

  Koh, Kyung Bong ^a   Kim, Chan Hyung ^a   Choi, Eun Hee ^a   Lee, Young Joon ^a   Seo, Won Youl ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; UNCLASSIFIED DRUG;

ADULT; AGGRESSION; ALLELE; ARTICLE; CONTROLLED STUDY; DSM-IV; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAMILTON SCALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATOFORM DISORDER; TPH1 GENE; UNDIFFERENTIATED SOMATOFORM DISORDER;

EID: 84861835150     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07342     Document Type: Article

References (43)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19. PubMed (Pubitemid 24028993)
2. Kessler RC, Berglund P, Demler O, et al National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. doi:10.101/jama.289.23.3095 PubMed (Pubitemid 37432885)
3. Guggenheim FG. Somatoform disorder. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:1504-1532.
4. de Waal MW, Arnold IA, Eekhof JA, et al. Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry. 2004;184(6):470-476. doi:10.192/bjp.184. 6.470 PubMed (Pubitemid 38725705)
5. Chang DF, Myers HF, Yeung A, et al. Shenjing shuairuo and the DSM-IV: diagnosis, distress, and disability in a Chinese primary care setting. Transcult Psychiatry. 2005;42(2):204-218. doi:10.17/136346150505260 PubMed (Pubitemid 40904029)
6. Leiknes KA, Finset A, Moum T, et al. Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders. Soc Psychiatry Psychiatr Epidemiol. 2007;42(9):698-710. doi:10.107/s0127-07-0218-8 PubMed (Pubitemid 47343009)
7. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40(2):288-295. PubMed (Pubitemid 24072594)
8. Peters EJ, Slager SL, McGrath PJ, et al. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry. 2004;9(9):879-889. doi:10.1038/sj.mp.401502 PubMed (Pubitemid 39273536)
9. Mann JJ. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology. 1999;21(suppl):99S- 105S. PubMed (Pubitemid 29396477)
10. Pickar D, Rubinow K. Pharmacogenomics of psychiatric disorders. Trends Pharmacol Sci. 2001;22(2):75-83. doi:10.1016/S0165-6147(0)01603-5 PubMed (Pubitemid 32146485)
11. Zill P, Baghai TC, Zwanzger P, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry. 2004;9(11):1030-1036. doi:10.1038/sj.mp.401525 PubMed (Pubitemid 39524291)
12. Zill P, Büttner A, Eisenmenger W, et al. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol. 2004;14(4):282-284. doi:10.1016/j. euroneuro.203.10.02 PubMed (Pubitemid 38649084)
13. Hennings A, Zill P, Rief W. Serotonin transporter gene promoter polymorphism and somatoform symptoms. J Clin Psychiatry. 2009;70(11):1536-1539. doi:10.408/JCP.08m04613 PubMed
14. Belous AR, Ramamoorthy S, Blakely RD, et al. The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders. Neurosci Behav Physiol. 2001;31(2):185-189. doi:10.1023/A:105268425375 PubMed (Pubitemid 32492401)
15. Tedlow J, Fava M, Uebelacker L, et al. Outcome definitions and predictors in depression. Psychother Psychosom. 1998;67(4-5):266-270. doi:10.159/01290 PubMed (Pubitemid 28386472)
16. Mammen OK, Kolko DJ, Pilkonis PA. Negative affect and parental aggression in child physical abuse. Child Abuse Negl. 2002;26(4):407-424. doi:10.1016/S0145-2134(02)0316-2 PubMed (Pubitemid 34462888)
17. Koh KB, Kim CH, Park JK. Predominance of anger in depressive disorders compared with anxiety disorders and somatoform disorders. J Clin Psychiatry. 2002;63(6):486-492. doi:10.408/JCP.v63n0604 PubMed (Pubitemid 34680356)
18. Koh KB, Kim DK, Kim SY, et al. The relation between anger expression, depression, and somatic symptoms in depressive disorders and somatoform disorders. J Clin Psychiatry. 2005;66(4):485-491. doi:10.408/JCP.v6n041 PubMed (Pubitemid 40593577)
19. Gould RA, Ball S, Kaspi SP, et al. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996;39(1):31-38. doi:10.1016/0165-0327(96)017-1 PubMed (Pubitemid 26235322)
20. Kellner R, Hernandez J, Pathak D. Self-rated inhibited anger, somatization and depression. Psychother Psychosom. 1992;57(3):102-107. doi:10.159/028582 PubMed
21. Koh KB, Kim DK, Kim SY, et al. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders. Psychiatry Res. 2008;160(3):372-379. doi:10.1016/j.psychres.207.06.03 PubMed
22. Seo DJ, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav. 2008;13(5):383-395. doi:10.1016/j.avb.208.06.03 PubMed
23. Asberg M, Schalling D, Traeskman-Bendz L, et al. Psychobiology of suicide, impulsivity, and related phenomena. In: Meltzer HY, ed. Psychopharmacology. The Third Generation of Progress. New York, NY: Raven Press; 1987.
24. Lee R, Coccaro E. The neuropsychopharmacology of criminality and aggression. Can J Psychiatry. 2001;46(1):35-44. PubMed (Pubitemid 32209343)
25. Bellivier F, Chaste P, Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 2004;124B(1):87-91. doi:10.102/ajmg.b.2015 PubMed (Pubitemid 38031599)
26. Mann JJ, Malone KM, Nielsen DA, et al. Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry. 1997;154(10):1451-1453. PubMed (Pubitemid 27415616)
27. Manuck SB, Flory JD, Ferrell RE, et al. Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry. 1999;45(5):603-614. doi:10.1016/S06-323(98)0375-8 PubMed (Pubitemid 29147369)
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
29. Hahn O, Hong J. Korean Version of Structured Clinical Interview Schedule for DSM-IV Axis I Disorders, Research Version. Seoul, Korea: Hana Medical Co; 2000.
30. Hahn O, Ahn J, Song S, et al. Development of Korean version of structured clinical interview schedule for DSM-IV Axis 1 disorders: interrater reliability. J Korean Neuropsychiatr Assoc. 2000;39(2):362-372.
31. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview Schedule for DSM-IV Axis I Disorders, Research Version, Patient/Nonpatient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996.
32. Seo S, Kwon S. Validation study of the Korean version of the Aggression Questionnaire. Korean J Clin Psychol. 2002;21(2):487-501.
33. Buss AH, Perry M. The Aggression Questionnaire. J Pers Soc Psychol. 1992;63(3):452-459. doi:10.1037/02-3514.63.3.452 PubMed
34. Rujescu D, Giegling I, Bondy B, et al. Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry. 2002;7(9):1023-1029. doi:10.1038/sj.mp.40128 PubMed (Pubitemid 35333060)
35. New AS, Gelernter J, Yovell Y, et al. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am J Med Genet. 1998;81(1):13-17. doi:10.102/(SICI)1096-8628(1980207)81:1<13:AID- AJMG3>3.0.CO;2-O PubMed (Pubitemid 28114844)
36. Staner L, Uyanik G, Correa H, et al. A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J Med Genet. 2002;114(5):553-557. doi:10.102/ajmg.10405 PubMed (Pubitemid 34680584)
37. Bellivier F, Henry C, Szöke A, et al. Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression. Neurosci Lett. 1998;255(3):143-146. doi:10.1016/S0304-3940(98)067-6 PubMed (Pubitemid 28506022)
38. Gizatullin R, Zaboli G, Jönsson EG, et al. Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry. 2006;59(4):295-300. doi:10.1016/j.biopsych.205.07. 034 PubMed (Pubitemid 43238353)
39. Souery D, Van Gestel S, Massat I, et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry. 2001;49(5):405-409. doi:10.1016/S06-323(0)01043-X PubMed (Pubitemid 32234302)
40. Tsai SJ, Hong CJ, Wang YC. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport. 1999;10(18):3773-3775. doi:10.1097/01756-1912160-010 PubMed
41. Serretti A, Cristina S, Lilli R, et al. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet. 2002;114(4):361-369. doi:10.102/ajmg.10356 PubMed (Pubitemid 34525233)
42. Furlong RA, Ho L, Rubinsztein JS, et al. No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am J Med Genet. 1998;81(3):245-247. doi:10.102/(SICI)1096-8628(1980508)81:3〈245:AID- AJMG8〉3.0.CO;2-V PubMed (Pubitemid 28211187)
43. Illi A, Setälä-Soikkeli E, Viikki M, et al. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport. 2009;20(12):1125-1128. PubMed